Follow
Tumor heterogeneity
Tumor heterogeneity describes differences between tumors. Tumor heterogeneity can refer to differences between (1) tumors in different patients, (2) cancer cells in an individual patient's tumor, or (3) a primary and metastatic tumor. Understanding the heterogeneity of a tumor can facilitate diagnosis and treatment.
-
OCT 27, 2025eBooksAddressing TCE Discovery Challenges with Expert Insights T-cell engagers (TCEs) are revolutionizing cancer immunotherapy ...Sponsored By: WuXi Biologics CRO ServicesSEP 11, 2025Health & Medicine
Glioblastoma multiforme (GBM) is a highly aggressive and malignant brain tumor that is resistant to many treatments. Unf ...Written By: Brian G. MorrealeSEP 08, 2025Cancer
Tumor heterogeneity, which refers to variations in the cellular and genetic components between cancer cells within a tum ...Written By: Katie KokolusAPR 14, 2025Cancer
Pancreatic cancer remains one of the most deadly malignancies, with nearly 52,000 deaths expected this year. With ...Written By: Katie KokolusMAR 20, 2025Immunology
Cancer is the rapid proliferation of malignant cells that permeate tissue and cause dysregulation of the body’s da ...Written By: Brian G. MorrealeJAN 04, 2024Immunology
Since the clinical application of anti-CTLA-4 and anti-PD-1 immunotherapy, treatments targeting the immune system (immun ...Written By: Brian G. MorrealeDEC 28, 2023Immunology
New technologies are rapidly transforming the way scientists study disease, particularly cancer. Due to unique biologica ...Written By: Brian G. MorrealeNOV 02, 2023Immunology
Cancer is a malignant disease referring to the uncontrollable proliferation of mutated cells. Millions of individuals ar ...Written By: Brian G. MorrealeOCT 26, 2023Immunology
Scientists from the University of California Davis (UC Davis) Comprehensive Cancer Center have recently published in Cel ...Written By: Brian G. MorrealeSEP 05, 2023Immunology
Cancer is a deadly disease with multiple risk factors. Risk factors are dependent on the type of cancer and each one is ...Written By: Brian G. MorrealeSEP 04, 2023Cancer
Metastasis is one of the main obstacles in treating cancer. Studying circulating tumor cells (CTCs) and CTC clusters at ...JUN 08, 2023Cancer
Glioblastoma (GBM), a particularly aggressive form of brain cancer, develops in the astrocyte cells found in the glial t ...Written By: Katie KokolusMAR 08, 2023Cancer
Genetic modification of mammalian cells has vast use in biotherapeutics development and basic research applications. An ...AUG 09, 2022Immunology
Scientists have been trying to stimulate the immune system to fight cancer for decades, and recent years have brought ma ...Written By: Carmen LeitchJUL 07, 2022Cell & Molecular Biology
Researchers have been able to use animal models to study human disease, but there are clear limitations to that approach ...Written By: Carmen LeitchJUL 03, 2022Cell & Molecular Biology
One of the deadliest types of cancer is pancreatic ductal adenocarcinoma (PDAC); the survival rate at five years after d ...Written By: Carmen LeitchJUN 27, 2022Cancer
Cancer develops when the DNA in our cells becomes altered, resulting in a gene mutation. DNA alterations can occur ...Written By: Katie KokolusFEB 11, 2022Cannabis Sciences
According to a recent study published in Oncotarget, cannabis extracts may harbor the potential to eventually be tailore ...Written By: Nadine HusamiSEP 21, 2021Cell & Molecular Biology
Transcriptomics studies are critical to understanding how biological systems work. However, this technique only estimate ...Sponsored By: IsoPlexis LeSEP 02, 2021Immunology
Innate lymphoid cells, or ILCs, are specialized immune cells that are increasingly entering the research spotlight. Thes ...Written By: Tara FernandesAUG 18, 2021Technology
All cells in a tumor share some genetic similarities, but also have key differences, often hindering effective treatment ...Written By: Ryan VingumJUN 16, 2021Cell & Molecular Biology
Metastatic cancer is the deadliest, and it can happen years after cancer has been treated to the point of remission. Met ...Written By: Carmen LeitchJUN 15, 2021Health & Medicine
Clinical biomarkers are critical for the acceleration of curative medicines. The identification of these novel clinical ...Sponsored By: IsoPlexis LeMAY 05, 2021Cancer
Drug resistant tumors present challenges in cancer treatment A significant challenge in the treatment of cancers is the ...Sponsored By: IsoPlexis Le
OCT 27, 2025
eBooks
Addressing TCE Discovery Challenges with Expert Insights T-cell engagers (TCEs) are revolutionizing cancer immunotherapy
...
Sponsored By:
WuXi Biologics CRO Services
SEP 11, 2025
Health & Medicine
Glioblastoma multiforme (GBM) is a highly aggressive and malignant brain tumor that is resistant to many treatments. Unf
...
Written By:
Brian G. Morreale
SEP 08, 2025
Cancer
Tumor heterogeneity, which refers to variations in the cellular and genetic components between cancer cells within a tum
...
Written By:
Katie Kokolus
APR 14, 2025
Cancer
Pancreatic cancer remains one of the most deadly malignancies, with nearly 52,000 deaths expected this year. With
...
Written By:
Katie Kokolus
MAR 20, 2025
Immunology
Cancer is the rapid proliferation of malignant cells that permeate tissue and cause dysregulation of the body’s da
...
Written By:
Brian G. Morreale
JAN 04, 2024
Immunology
Since the clinical application of anti-CTLA-4 and anti-PD-1 immunotherapy, treatments targeting the immune system (immun
...
Written By:
Brian G. Morreale
DEC 28, 2023
Immunology
New technologies are rapidly transforming the way scientists study disease, particularly cancer. Due to unique biologica
...
Written By:
Brian G. Morreale
NOV 02, 2023
Immunology
Cancer is a malignant disease referring to the uncontrollable proliferation of mutated cells. Millions of individuals ar
...
Written By:
Brian G. Morreale
OCT 26, 2023
Immunology
Scientists from the University of California Davis (UC Davis) Comprehensive Cancer Center have recently published in Cel
...
Written By:
Brian G. Morreale
SEP 05, 2023
Immunology
Cancer is a deadly disease with multiple risk factors. Risk factors are dependent on the type of cancer and each one is
...
Written By:
Brian G. Morreale
SEP 04, 2023
Cancer
Metastasis is one of the main obstacles in treating cancer. Studying circulating tumor cells (CTCs) and CTC clusters at
...
JUN 08, 2023
Cancer
Glioblastoma (GBM), a particularly aggressive form of brain cancer, develops in the astrocyte cells found in the glial t
...
Written By:
Katie Kokolus
MAR 08, 2023
Cancer
Genetic modification of mammalian cells has vast use in biotherapeutics development and basic research applications. An
...
AUG 09, 2022
Immunology
Scientists have been trying to stimulate the immune system to fight cancer for decades, and recent years have brought ma
...
Written By:
Carmen Leitch
JUL 07, 2022
Cell & Molecular Biology
Researchers have been able to use animal models to study human disease, but there are clear limitations to that approach
...
Written By:
Carmen Leitch
JUL 03, 2022
Cell & Molecular Biology
One of the deadliest types of cancer is pancreatic ductal adenocarcinoma (PDAC); the survival rate at five years after d
...
Written By:
Carmen Leitch
JUN 27, 2022
Cancer
Cancer develops when the DNA in our cells becomes altered, resulting in a gene mutation. DNA alterations can occur
...
Written By:
Katie Kokolus
FEB 11, 2022
Cannabis Sciences
According to a recent study published in Oncotarget, cannabis extracts may harbor the potential to eventually be tailore
...
Written By:
Nadine Husami
SEP 21, 2021
Cell & Molecular Biology
Transcriptomics studies are critical to understanding how biological systems work. However, this technique only estimate
...
Sponsored By:
IsoPlexis Le
SEP 02, 2021
Immunology
Innate lymphoid cells, or ILCs, are specialized immune cells that are increasingly entering the research spotlight. Thes
...
Written By:
Tara Fernandes
AUG 18, 2021
Technology
All cells in a tumor share some genetic similarities, but also have key differences, often hindering effective treatment
...
Written By:
Ryan Vingum
JUN 16, 2021
Cell & Molecular Biology
Metastatic cancer is the deadliest, and it can happen years after cancer has been treated to the point of remission. Met
...
Written By:
Carmen Leitch
JUN 15, 2021
Health & Medicine
Clinical biomarkers are critical for the acceleration of curative medicines. The identification of these novel clinical
...
Sponsored By:
IsoPlexis Le
MAY 05, 2021
Cancer
Drug resistant tumors present challenges in cancer treatment A significant challenge in the treatment of cancers is the
...
Sponsored By:
IsoPlexis Le